01
Cash & equivalents decreased 7.9%
Cash & equivalents changed -7.9% from the comparable as-filed period.
$160.3M→$147.6MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTCartesian Therapeutics, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -7.9% from the comparable as-filed period.
Net income changed -0.7% from the comparable as-filed period.
Operating income changed -33.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
RNAC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001453687-26-000101SEC ↗8-KAug 6, 2026Period Aug 6, 20260001453687-26-000100SEC ↗8-KJun 17, 2026Period Jun 12, 20260001453687-26-000090SEC ↗8-KJun 9, 2026Period Jun 9, 20260001140361-26-024556SEC ↗8-KMay 26, 2026Period May 22, 20260001453687-26-000087SEC ↗10-QApr 30, 2026Period Mar 31, 20260001453687-26-000082SEC ↗8-KApr 30, 2026Period Apr 30, 20260001453687-26-000081SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +37.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -36.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0002064832-26-000149